NeuroPace, Inc.
NeuroPace, Inc.（NPCE）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · NPCE · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
1
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
NeuroPace, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
NPCE 季度内部人买卖趋势
NPCE 内幕交易卖出 · NPCE 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · NPCE CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NPCE 高管卖出股份 · NPCE 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 5, 2026 | Huennekens R Scott Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Fischer Frank M Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Geiger Uri Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Kumar Rakhi Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Ryan Renee Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Andrade Lisa Director | Award | 2,890 | — | Form 4 |
| Jun 3, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 1,255 | $20K | Form 4 |
| May 27, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 1,126 | $19K | Form 4 |
| May 27, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 358 | $6K | Form 4 |
| May 15, 2026 | Williams Patrick F. CFO | Award | 16,820 | — | Form 4 |
| May 15, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Award | 5,460 | — | Form 4 |
| May 15, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Award | 45,880 | — | Form 4 |
| Mar 24, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 1,341 | $18K | Form 4 |
| Mar 20, 2026 | Geiger Uri Director | Award | 913 | $12K | Form 4 |
| Mar 20, 2026 | LACOB JOSEPH Director | Award | 865 | $11K | Form 4 |
| Mar 20, 2026 | Kumar Rakhi Director | Award | 1,153 | $15K | Form 4 |
| Mar 20, 2026 | Fischer Frank M Director | Award | 1,826 | $24K | Form 4 |
| Dec 15, 2025 | Morrell Martha CHIEF MEDICAL OFFICER | Sale | 25,000 | $399K | Form 4 |
| Mar 3, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 1,340 | $19K | Form 4 |
| Mar 3, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 5,023 | $69K | Form 4 |
| Feb 27, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 1,126 | $16K | Form 4 |
| Feb 27, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 358 | $5K | Form 4 |
| Feb 20, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 3,412 | $49K | Form 4 |
| Dec 19, 2025 | LACOB JOSEPH Director | Award | 678 | $11K | Form 4 |
| Dec 19, 2025 | Kumar Rakhi Director | Award | 904 | $15K | Form 4 |
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 3
股数
1,255
均价
$15.88
总金额
$20K
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
日期
May 27
股数
1,126
均价
$17.06
总金额
$19K
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
日期
Mar 3
股数
5,023
均价
$13.83
总金额
$69K
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
日期
Feb 27
股数
1,126
均价
$14.58
总金额
$16K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NPCE 内幕交易
NPCE 内幕交易
NeuroPace, Inc.（NPCE）内幕交易数据来源于公司内部人（包括Morrell Martha (CHIEF MEDICAL OFFICER), Becker Joel (CHIEF EXECUTIVE OFFICER · Director), Fischer Frank M (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。NPCE内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看NeuroPace, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
NPCE 内幕交易 · 5个问题NeuroPace, Inc.（NPCE）的内部人包括高管和董事，如Morrell Martha (CHIEF MEDICAL OFFICER), Becker Joel (CHIEF EXECUTIVE OFFICER · Director), Fischer Frank M (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026